AQR Capital Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

AQR Capital Management’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-23,070	Closed	-$1.11M	–	2208
2020 Q1	$1.11M	Buy	+23,070	New	+$1.07M	﹤0.01%	1298
2019 Q4	–	Sell	-23,905	Closed	-$565K	–	2221
2019 Q3	$565K	Sell	23,905 -9,742	-29%	-$289K	﹤0.01%	1720
2019 Q2	$1.01M	Buy	33,647 +7,549	+29%	+$173K	﹤0.01%	1492
2019 Q1	$585K	Buy	26,098 +2,137	+9%	+$45.9K	﹤0.01%	1754
2018 Q4	$436K	Buy	+23,961	New	+$376K	﹤0.01%	1828

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

AQR Capital Management's RARX Position: Q2 2020 in Review

AQR Capital Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 23,070 shares — an estimated $1.11M sold.

AQR Capital Management first reported a position in RARX in Q4 2018 and held it in 5 quarters. The position peaked at $1.11M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

AQR Capital Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
AQR Capital Management sold 23,070 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $1.11M.
AQR Capital Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 5 quarters.
AQR Capital Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $1.11M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on AQR Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.